Patents by Inventor Kyoung Soon Kim

Kyoung Soon Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Metabolome sampling and analysis method for analyzing metabolome during synthetic gas fermentation of synthetic gas fermentation microorganisms
    Patent number: 11988651
    Abstract: The present invention relates to a metabolome sampling and analysis method for analyzing metabolome during synthetic gas fermentation of a synthetic gas fermentation microorganisms, the method establishing an optimal condition for metabolome sampling and enabling a glucose culture and a synthetic gas culture of the synthetic gas fermentation microorganisms to be distinguished by using a selected metabolomic biomarker.
    Type: Grant
    Filed: February 21, 2019
    Date of Patent: May 21, 2024
    Assignees: Korea University Research and Business Foundation, Korea Institute of Science and Technology
    Inventors: Kyoung Heon Kim, Young Soon Um, Jung Yeon Kim, Joongsuk Kim
  • Process for the preparation of chiral ketone intermediates useful for the preparation of flavopiridol and analogs
    Patent number: 5908934
    Abstract: A process for the preparation of compounds of formula I ##STR1## where R.sup.1, R.sup.2, R.sup.3, m, n and q are as defined herein; which comprises the steps of (a)reacting a compound of formula III ##STR2## with a chiral acid in an organic solvent to form a salt of a compound of formula I and (b) treating the salt of a compound of formula I with an aqueous base to obtain the compounds of formula I. Compounds of formula I are intermediates useful in the preparation of protein kinase inhibitors.
    Type: Grant
    Filed: September 12, 1997
    Date of Patent: June 1, 1999
    Assignee: Bristol-Myers Squibb Company
    Inventor: Kyoung Soon Kim
  • 2-thio or 2-oxo flavopiridol analogs
    Patent number: 5849733
    Abstract: Compounds of the formula I ##STR1## and pharmaceutically acceptable salts thereof, wherein X, R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, m and n are as defined in the disclosure. The compounds of formula I are protein kinase inhibitors and are useful in the treatment of proliferative diseases.
    Type: Grant
    Filed: May 1, 1997
    Date of Patent: December 15, 1998
    Assignee: Bristol-Myers Squibb Co.
    Inventor: Kyoung Soon Kim